Abstract
The foundations of evidence-based practice are the triad of patient values and preferences, healthcare professional experience, and best available evidence, used together to inform clinical decision-making. Within the field of rhabdomyosarcoma, collaborative groups such as the European Paediatric Soft Tissue Sarcoma Group (EpSSG) have worked to develop evidence to support this process. We have explored many of the key research developments within this review, including patient and public involvement, decision-making research, research into areas other than drug development, core outcome sets, reporting and dissemination of research, evidence synthesis, guideline development and clinical decision rules, research of research methodologies, and supporting research in RMS.
Reference30 articles.
1. New Evidence Pyramid;Murad;BMJ Evid.-Based Med.,2016
2. Research Priorities for Young People with Cancer: A UK Priority Setting Partnership with the James Lind Alliance;Aldiss;BMJ Open,2019
3. (2022, November 24). Children’s Cancer|James Lind Alliance. Available online: https://www.jla.nihr.ac.uk/priority-setting-partnerships/childrens-cancer/.
4. (2022, November 24). Pediatric Cancer (Canada)|James Lind Alliance. Available online: https://www.jla.nihr.ac.uk/priority-setting-partnerships/pediatric-cancer/.
5. Pearson H, H., Bryan, G., Kayum, C., Gibson, F., and Darlington, A.-S. (2022). Parent Values and Preferences Underpinning Treatment Decision-Making in Poor-Prognosis Childhood Cancer: A Scoping Review. BMC Pediatr., 22.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献